Jeffrey Nau

Chief Executive Officer at

Aviceda Therapeutics, Inc.

51 year

56 connections

Health Technology

Consumer Services

Commercial Services

Profile

Jeffrey A. Nau is President, Chief Executive Officer & Director at Aviceda Therapeutics, Inc. since 2025.
Treasurer & Director at BioNJ, Inc. since 2020.
Director at Ophthalmology Foundation since 2023.
Formerly President & Chief Executive Officer at Oyster Point Pharma, Inc. from 2017 to 2023.
Vice President-Clinical & Medical Affairs at IVERIC bio, Inc. from 2013 to 2017.
Director-Medical Sciences at Genentech, Inc. from 2011 to 2013.
Vice President-Medical & Clinical Affairs at NeoVista, Inc. from 2006 to 2011.
Chief Operating Officer at Kalaris Therapeutics, Inc. in 2025.
Clinical Program Manager at Genaera Pharmaceuticals.
Research Fellow at Wills Eye Health System & Wills Eye Institute.
President-Eye Care Division at Viatris, Inc. Education includes a doctorate from Walden University LLC, graduate degree from Drexel University College of Medicine, and undergraduate degree from Stony Brook University.

Jeffrey Nau active positions

Companies	Position	Start
BioNJ, Inc. BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey	Director/Board Member	13/02/2020
Ophthalmology Foundation Ophthalmology Foundation Miscellaneous Commercial ServicesCommercial Services The Ophthalmology Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing ophthalmic education and improving eye care worldwide, with a focus on underserved and low-resource regions. The private company is based in San Francisco, CA. The organization empowers vision care through accessible, high-quality education, faculty development, and professional growth for ophthalmologists and eye care professionals. Key initiatives include internationally recognized, low-cost online examinations aligned with American Academy of Ophthalmology standards, offered biannually at local host centers worldwide to reduce travel barriers. The foundation plans to expand exam offerings with new subspecialty tests in retina and glaucoma launching in 2027. Top-performing candidates outside the U.S. may receive travel grants to attend international conferences or pursue specialized training. Faculty development is a core focus, with programs designed to enhance teaching skills through mentorships, symposia, workshops, webinars, simulation-based education, and online courses offering continuing professional development credits. The foundation’s educator’s certificate program certifies teaching competence, enabling educators to participate as faculty in educational interventions. Its faculty development committee oversees program quality and volunteer recruitment. Additional offerings include subspecialty fellowships awarding 80-100 grants annually across 20 areas, accreditation of residency programs to meet international standards, and collaborative partnerships with leading institutions and organizations worldwide. The foundation emphasizes equity, inclusion, and ethical standards, tailoring programs to regional needs through an international advisory committee.	Director/Board Member	29/06/2023
Aviceda Therapeutics, Inc. Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Chief Executive Officer	01/04/2025

All active positions of Jeffrey Nau

Former positions of Jeffrey Nau

Companies	Position	End
VIATRIS INC.	Corporate Officer/Principal	01/01/2024
OYSR POIN	Chief Executive Officer	01/01/2023
IVERIC BIO, INC.	Chief Tech/Sci/R&D Officer	01/03/2017
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Chief Tech/Sci/R&D Officer	01/07/2013

See the detail of Jeffrey Nau's experience

Training of Jeffrey Nau

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Nau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
NeoVista, Inc. NeoVista, Inc. Medical SpecialtiesHealth Technology Develops a device-based therapy for age-related macular degeneration	Health Technology
Walden University LLC Walden University LLC Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stony Brook University Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Genaera Pharmaceuticals
Wills Eye Health System & Wills Eye Institute Wills Eye Health System & Wills Eye Institute Medical/Nursing ServicesHealth Services Operates eye hospital	Health Services
IVERIC bio, Inc. IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases	Health Technology
BioNJ, Inc. BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey	Commercial Services
Drexel University College of Medicine Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases	Health Technology
Viatris, Inc. Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Health Technology
Aviceda Therapeutics, Inc. Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology	Commercial Services
Ophthalmology Foundation Ophthalmology Foundation Miscellaneous Commercial ServicesCommercial Services The Ophthalmology Foundation is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing ophthalmic education and improving eye care worldwide, with a focus on underserved and low-resource regions. The private company is based in San Francisco, CA. The organization empowers vision care through accessible, high-quality education, faculty development, and professional growth for ophthalmologists and eye care professionals. Key initiatives include internationally recognized, low-cost online examinations aligned with American Academy of Ophthalmology standards, offered biannually at local host centers worldwide to reduce travel barriers. The foundation plans to expand exam offerings with new subspecialty tests in retina and glaucoma launching in 2027. Top-performing candidates outside the U.S. may receive travel grants to attend international conferences or pursue specialized training. Faculty development is a core focus, with programs designed to enhance teaching skills through mentorships, symposia, workshops, webinars, simulation-based education, and online courses offering continuing professional development credits. The foundation’s educator’s certificate program certifies teaching competence, enabling educators to participate as faculty in educational interventions. Its faculty development committee oversees program quality and volunteer recruitment. Additional offerings include subspecialty fellowships awarding 80-100 grants annually across 20 areas, accreditation of residency programs to meet international standards, and collaborative partnerships with leading institutions and organizations worldwide. The foundation emphasizes equity, inclusion, and ethical standards, tailoring programs to regional needs through an international advisory committee.	Commercial Services